Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Weight loss drug roll-out sends Hims & Hers stock soaring
03:50am, Tuesday, 21'st May 2024
Weight loss drugs helped Hims & Hers Health (NYSE:HIMS) put value on, with the stock soaring some 30% higher in ‘afterhours' trade on Monday. The online consumer healthcare brand last night announce
Celebrity Fitness Trainer Jillian Michaels weighs in on Hims & Hers offering weight-loss drugs
08:40pm, Monday, 20'th May 2024
Hosted by Brian Sullivan, “Last Call” is a fast-paced, entertaining business show that explores the intersection of money, culture and policy. Tune in Monday through Friday at 7 p.m.
Dr. Craig Primack talks Hims & Hers launching its own GLP-1 offering as demand rises
06:43pm, Monday, 20'th May 2024
Dr. Craig Primack, Hims & Hers SVP of Weight Management, joins 'Closing Bell Overtime' to talk the company offering a GLP-1 drug through its platform.
Hims & Hers Health Stock Jumps Nearly 28% on Plans to Offer GLP-1 Weight-Loss Drugs
05:15pm, Monday, 20'th May 2024
Shares of Hims & Hers Health (HIMS) surged close to 28% Monday after the telehealth company said it would begin offering GLP-1 injections as part of its weight-loss package of drugs.
Hims & Hers Stock Hits 3-Year High After Announcing $199 Weight-Loss Alternative To Wegovy
04:09pm, Monday, 20'th May 2024
Shares of telehealth company Hims & Hers Health closed at a three-year high Monday after the company announced a weight-loss treatment starting at $199 a month that will compete with Novo Nordisk's We
Three-Stock Lunch: Microsoft, Johnson Controls and Hims & Hers Health
03:26pm, Monday, 20'th May 2024
David Trainer, New Constructs CEO, joins 'Power Lunch' to discuss plays for three stocks: Microsoft, Johnson Controls, and Hims & Hers Health.
HIMS Stock Alert: Hims & Hers Shares Rocket on Weight Loss Injections
03:16pm, Monday, 20'th May 2024
Shares of Hims & Hers Health (NYSE: HIMS ) stock are skyrocketing higher by over 25% after the telehealth company announced that it would provide access to GLP-1 weight-loss injections. Hims & Hers ha
Hims & Hers Adds Weight-Loss Injections, Stock Soars
02:47pm, Monday, 20'th May 2024
Hims & Hers Health Inc (NYSE:HIMS) stock is soaring today, up 29.4% to trade at $18.85 and earlier hitting a three-year high of $20.11.
Hims & Hers rallies after announcing access to GLP-1 injections
12:23pm, Monday, 20'th May 2024
Hims & Hers Health Inc shares rocketed 31% higher on Monday after announcing it will provide access to injectable GLP-1 medications. These injections serve as a more affordable alternative to branded
Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings
12:01pm, Monday, 20'th May 2024
Hims & Hers Health Inc.'s stock HIMS, +32.81% jumped more than 30% Monday morning after the health and wellness platform said it would offer compounded GLP-1 drugs — products that the Food and Drug
Tech Surge Boosts Nasdaq to Record Highs
11:48am, Monday, 20'th May 2024
Tech Surge Boosts Nasdaq to Record Highs The S&P 500 is wavering below all-time highs as well Laura McCandless Deputy Editor May 20, 2024 at 11:48 AM SPX|IXIC|DJI All three major indexes are higher mi
The case for the overvalued Hims & Hers stock
11:38am, Monday, 20'th May 2024
Hims & Hers Health (NYSE: HIMS) stock price is doing well, helped by its strong growth and demand for its core products. It soared by over 30% this year and by more than 112% this year.
Is Hims & Hers Health (HIMS) a Buy as Wall Street Analysts Look Optimistic?
10:36am, Monday, 20'th May 2024
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
09:00am, Monday, 20'th May 2024
The GLP-1 market has faced supply constraints in recent months as the drugs like Ozempic and Wegovy skyrocket in popularity.
Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers
09:00am, Monday, 20'th May 2024
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc., the leading health and wellness platform, today announced the addition of GLP-1 injections to its comprehensive weight loss portfolio, giving
